期刊文献+

Sepsis的定义和治疗进展——在隧道尽头的亮点? 被引量:1

暂未订购
导出
摘要 Sepsis一词源于希文,是"腐烂"(decay)的意思[1].对它的研究报道,在Medline网上已达70 000余条,公认为是近代危急医学重点关注的问题.
作者 李德馨
出处 《国外医学(麻醉学与复苏分册)》 2003年第4期193-195,共3页 Foreign Medical Sciences(Anesthesilolgy and Resuscitation)
  • 相关文献

参考文献15

  • 1李德馨.世纪之交关注ARDS[J].国外医学(麻醉学与复苏分册),2001,22(3):129-130. 被引量:7
  • 2.英汉医学词汇[M].北京:人民卫生出版社,1984.1259.
  • 3李德馨.危急医学的一个亮点——重组人体活化蛋白C[J].国外医学(麻醉学与复苏分册),2002,23(1):2-3. 被引量:1
  • 4Bone RG, Balk RA, Carra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. Crit care Med, 1992,20: 864-874.
  • 5Levy MM,Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS International sepsis Definitions Conference. Crit Care Med,2003,31 (4) : 1250-1256.
  • 6Vincent J-L, Abraham E, Annane D, et al. Reducing mortality in sepsis: New directions. Crit care, 2002,6(supl3) : S1-S18.
  • 7Booke M, Westphal M. Treatment of sepsis and septic shock:is there a light at the end of the tunnel? Curr. Opin in Anesthesiolgy,2003,16(2) : 101-104.
  • 8Ricard JD. Are we really reducing tidal volume-And should we? ( Editorial). Am J Respir Crit Care Med,2003,167(5):1297.
  • 9Matthay MA, Zimmerman GA, Esmon C, et al. NHLBI workshop summary: Future research directions in acute lung injury. Am J Respir Crit Care Med,2003,167(7) : 1027.
  • 10Bernard GR. Drotrecogin alfa(activated) (recombinant human activated proteinc) for the freatment of severe sepsis. Crit Care Med,2003,31 ( 1 ) supl: S85-S93.

二级参考文献6

  • 1Ball J, Venn R. Meeting report of The 21st international symposium on intensive care and emergency medicine,Brussels, Belgium, 20~ 23 March 2001; Crit Care, 2001; 5:138~141
  • 2Webster NR:Evidence based practice in intensive care-light on the horigon? (Editorial)Br J Anesth 2001,87 (3): 377 ~ 379
  • 3Dhainaut JF. Introduction to the Margaux conference on critical illness :Activation of the coagulation system in critical illness ,Nov11 ~ 13, 1999, Crit Care Med, 2000; 28 ( 9 ) : S1 ~S3
  • 4Dhainaut JF, Giroir B.Opal S. Introduction to the 2nd Margaux conference on critical illness sepsis: interface between inflammation,coagulation,and the endothelium. Crit Care Med, 2001 ;29(7) :S1 ~S3
  • 5Bernard GR, Vincent JL, Laterre PF, et al [for the recombinant ttuman activated protein C worldwide evaluation in seveve sepsis (PROWESS)study group ]. efficacy and safety of recombinant human activated protein C for severe sepsis. http:∥www. nejm. org/early release. feb 9. 2001 和N Eng J Med,2001;334:699~709
  • 6Matthay MA. Severe sepsis-A new treatment with both anticoagulant and antiinflammatory properties. N Eng J Med,2001; 334: 697

共引文献6

同被引文献6

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部